| __timestamp | Eli Lilly and Company | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 4733600000 | 12122000 |
| Thursday, January 1, 2015 | 4796400000 | 13380000 |
| Friday, January 1, 2016 | 5243900000 | 21221000 |
| Sunday, January 1, 2017 | 5281800000 | 26887000 |
| Monday, January 1, 2018 | 5051200000 | 27863000 |
| Tuesday, January 1, 2019 | 5595000000 | 55908000 |
| Wednesday, January 1, 2020 | 6085700000 | 59392000 |
| Friday, January 1, 2021 | 7025900000 | 69012000 |
| Saturday, January 1, 2022 | 7190800000 | 36082000 |
| Sunday, January 1, 2023 | 9313400000 | 24537000 |
| Monday, January 1, 2024 | 14271000000 |
Data in motion
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Eli Lilly and Company and Ligand Pharmaceuticals Incorporated are two giants in this field, each with a distinct approach to research and development (R&D) investment. Over the past decade, Eli Lilly has consistently outpaced Ligand in R&D spending, with a staggering 1,900% more investment in 2023 alone. This trend highlights Eli Lilly's commitment to innovation, as their R&D expenses have grown from approximately $4.7 billion in 2014 to over $9.3 billion in 2023, marking a 97% increase. In contrast, Ligand's R&D spending peaked in 2021 at around $69 million, before declining to $24 million in 2023. This disparity underscores the different scales and strategies of these companies, with Eli Lilly's robust investment potentially driving future breakthroughs in healthcare.
R&D Spending Showdown: Eli Lilly and Company vs Dr. Reddy's Laboratories Limited
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Madrigal Pharmaceuticals, Inc.
Comparing Innovation Spending: Eli Lilly and Company and Opthea Limited
Comparing Innovation Spending: Eli Lilly and Company and Ionis Pharmaceuticals, Inc.
Eli Lilly and Company or Alkermes plc: Who Invests More in Innovation?
Eli Lilly and Company vs Veracyte, Inc.: Strategic Focus on R&D Spending
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Amgen Inc. and Ligand Pharmaceuticals Incorporated
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
R&D Spending Showdown: Vericel Corporation vs Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Ligand Pharmaceuticals Incorporated and Evotec SE